Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Stroke

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 97 articles: HTML format

Single Articles

February 2026
1. CARPENTER CR
   Alteplase and aspirin within 4.5 h of severe vision loss due to CRAO did not differ for improvement in visual acuity at 1 mo.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05284.
   PubMed     Abstract available
   
   
   
2. SHARMA M, Srivastava A
   In patients with ischemic stroke, NVAF, and ASCVD, adding an antiplatelet to OAC therapy did not affect net clinical benefit at 2 y.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05308.
   PubMed     Abstract available
   
   
   
3. KELSEY MD
   In patients with CAD, clopidogrel vs. aspirin monotherapy reduces MACCE without increasing major bleeding.
   Ann Intern Med. 2026;179:JC16.
   PubMed     Abstract available
   
   
   December 2025
4. YAN VKC, Blais JE, Gamble JM, Chan EWY, et al
   Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.
   Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-00662.
   PubMed     Abstract available
   
   
   
5. STEEN JP, Klatt KC, Chang Y, Guyatt GH, et al
   Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events : A Risk Stratified Systematic Review of Randomized Trials.
   Ann Intern Med. 2025 Dec 16. doi: 10.7326/ANNALS-25-02229.
   PubMed     Abstract available
   
   
   
6. GUL S, Uchino K
   Alteplase 4.5 to 24 h after stroke with potentially salvageable brain tissue increased independence at 90 d.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04796.
   PubMed     Abstract available
   
   
   
7. GUL S, Uchino K
   In anterior circulation LVO stroke, adding IV alteplase to thrombectomy increased intracranial hemorrhage at 7 d.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04797.
   PubMed     Abstract available
   
   
   
8. MEI DA, Romiti GF
   In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04685.
   PubMed     Abstract available
   
   
   
9. LEIVA O, Elgendy IY
   In adults with MI and LVEF >40% after invasive care, beta-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y.
   Ann Intern Med. 2025;178:JC134.
   PubMed     Abstract available
   
   
   
10. LEIVA O, Elgendy IY
    In adults with MI and LVEF >/=40%, beta-blocker therapy reduced a composite adverse outcome at a median 3.5 y.
    Ann Intern Med. 2025;178:JC135.
    PubMed     Abstract available
    
    
    
11. LIM LS
    In healthy older adults, low-dose aspirin for a median 4.7 y did not reduce MACE but increased major hemorrhage at a median 8.3 y.
    Ann Intern Med. 2025;178:JC139.
    PubMed     Abstract available
    
    
    November 2025
12. GANDH AS, Siddu M, Jillella D
    In minor stroke, adding IV thrombolysis to nonthrombolytic usual care does not increase excellent functional outcome at 90 d.
    Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-04399.
    PubMed     Abstract available
    
    
    
13. GODOY A, Douketis JD
    In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo.
    Ann Intern Med. 2025;178:JC127.
    PubMed     Abstract available
    
    
    September 2025
14. JUNG M, Reisert M, Rieder H, Rospleszcz S, et al
    Association Between Body Composition and Cardiometabolic Outcomes : A Prospective Cohort Study.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-24-01863.
    PubMed     Abstract available
    
    
    
15. KOTANIDIS CP, Gorey S, Marwah H, Pearl A, et al
    Revision of Research Abstracts Through the Editorial Process.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-02250.
    PubMed    
    
    
    
16. KHAN F, Hill MD
    In carotid stenosis with low or intermediate risk for stroke, adding revascularization to OMT did not improve outcomes at 2 y.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03078.
    PubMed     Abstract available
    
    
    
17. LO BM
    In acute ischemic stroke with large core infarct, EVT improves mRS scores but increases symptomatic intracranial hemorrhage at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03146.
    PubMed     Abstract available
    
    
    
18. ALBERTS MJ
    In ischemic stroke prevention, apixaban and aspirin do not differ for intracranial hemorrhage events.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03295.
    PubMed     Abstract available
    
    
    
19. FIELD TS
    In AIS due to LVO presenting within 4.5 h of onset, adding tenecteplase to EVT increased functional independence at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03337.
    PubMed     Abstract available
    
    
    August 2025
20. SMITH KC, Gaziano TA, Mushlin AI, Cutler DM, et al
    Effect of Systolic Blood Pressure Measurement Error on the Cost-Effectiveness of Intensive Blood Pressure Targets.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00560.
    PubMed     Abstract available
    
    
    
21. FIELD TS
    At 4.5 to 24 h after posterior circulation stroke onset, alteplase vs. standard medical care increased 90-d functional independence.
    Ann Intern Med. 2025 Aug 5. doi: 10.7326/ANNALS-25-02446.
    PubMed     Abstract available
    
    
    July 2025
22. MONTANE B, Zhang S, Wolfe JD, Prime S, et al
    Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253.
    PubMed     Abstract available
    
    
    June 2025
23. SAEED A, Mulukutla SR, Thoma F, Lemon L, et al
    Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
    Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
    PubMed     Abstract available
    
    
    
24. KATSANOS AH, Douketis JD
    In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01772.
    PubMed     Abstract available
    
    
    
25. BATUR P
    Some combined and progestin-only contraceptives were linked to increased risk for ischemic stroke and myocardial infarction.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01774.
    PubMed     Abstract available
    
    
    May 2025
26. ALBERTS MJ
    In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01330.
    PubMed     Abstract available
    
    
    
27. LO B
    In ischemic stroke, IV thrombolysis >4.5 h after symptom onset vs. standard medical care improves 90-d functional outcomes.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01326.
    PubMed     Abstract available
    
    
    
28. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    PubMed     Abstract available
    
    
    
29. DONATO AA, Rahimian S
    Non-vitamin K oral anticoagulants and aspirin do not differ for major bleeding and intracranial hemorrhage at a mean 20 mo.
    Ann Intern Med. 2025;178:JC58.
    PubMed     Abstract available
    
    
    April 2025
30. ABDEL-QADIR H, Gunn M, Fang J, Odugbemi T, et al
    Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses : A Retrospective Cohort Study.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01967.
    PubMed     Abstract available
    
    
    
31. YNALVEZ LA, Deswal A
    In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y.
    Ann Intern Med. 2025;178:JC43.
    PubMed     Abstract available
    
    
    
32. WANG Y, Lip GYH
    In HF with mildly reduced or preserved ejection fraction, finerenone reduced CV death and worsening HF, regardless of baseline LVEF.
    Ann Intern Med. 2025;178:JC44.
    PubMed     Abstract available
    
    
    February 2025
33. LEE YJ, Gao X, Lee SH, Kan J, et al
    De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systemic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials.
    Ann Intern Med. 2025 Feb 18. doi: 10.7326/ANNALS-24-03102.
    PubMed     Abstract available
    
    
    
34. SMETANA GW, Gelfand EV, Tung P, Burns RB, et al
    How Would You Manage This Patient With Recent-Onset Atrial Fibrillation? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03490.
    PubMed     Abstract available
    
    
    
35. SHARMA M, Srivastava A
    In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03879.
    PubMed     Abstract available
    
    
    
36. KOROMPOKI E, Douketis JD
    In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03608.
    PubMed     Abstract available
    
    
    
37. RACO MD, Raco DL
    In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03735.
    PubMed     Abstract available
    
    
    January 2025
38. EAPEN BC, Tran J, Ballard-Hernandez J, Buelt A, et al
    Stroke Rehabilitation: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.
    Ann Intern Med. 2025 Jan 21. doi: 10.7326/ANNALS-24-02205.
    PubMed     Abstract available
    
    
    
39. BATES ER
    In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
    PubMed     Abstract available
    
    
    
40. MORENO R
    In asymptomatic severe AS, early surgery vs. conservative therapy reduced a composite of death, MI, stroke, or HF hospitalization at 63 mo.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03367.
    PubMed     Abstract available
    
    
    December 2024
41. DONATO AA, Goswami V
    In acute ischemic stroke and a large infarct, adding EVT to medical treatment improved functional outcome at 12 mo.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02886.
    PubMed     Abstract available
    
    
    
42. LIBMAN H, Anderson TS, Rangan VV, Reynolds EE, et al
    How Would You Manage This Patient With Gastroesophageal Reflux Symptoms? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2024;177:1695-1701.
    PubMed     Abstract available
    
    
    November 2024
43. ROMITI GF, Talerico G
    In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA(2)DS(2)-VASc >4.
    Ann Intern Med. 2024;177:JC125.
    PubMed     Abstract available
    
    
    October 2024
44. WOODRUFF RC, Kaholokula JK, Riley L, Tong X, et al
    Cardiovascular Disease Mortality Among Native Hawaiian and Pacific Islander Adults Aged 35 Years or Older, 2018 to 2022.
    Ann Intern Med. 2024 Oct 15. doi: 10.7326/M24-0801.
    PubMed     Abstract available
    
    
    
45. SHARMA M, Srivastva A
    In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02228.
    PubMed     Abstract available
    
    
    
46. DAVIDSON MB
    In adults with hypertension and high CV risk, intensive vs. standard BP-lowering therapy reduced major vascular events.
    Ann Intern Med. 2024;177:JC111.
    PubMed     Abstract available
    
    
    September 2024
47. KODUMURI N, Siddu M, Jillella D
    In acute ischemic stroke with a large core infarct, endovascular thrombectomy reduced disability at 90 d.
    Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-01578.
    PubMed     Abstract available
    
    
    August 2024
48. DUNBAR KB
    Gastroesophageal Reflux Disease.
    Ann Intern Med. 2024;177:ITC113-ITC128.
    PubMed     Abstract available
    
    
    
49. CLIFFORD C, Yan AT
    After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
    Ann Intern Med. 2024;177:JC86.
    PubMed     Abstract available
    
    
    July 2024
50. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed     Abstract available
    
    
    
51. BARNES GD
    In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00652.
    PubMed     Abstract available
    
    
    June 2024
52. SEBASTIAN IA, Hill MD
    In ischemic stroke, adding IV thrombolysis
    Ann Intern Med. 2024 Jun 4. doi: 10.7326/ANNALS-24-00519.
    PubMed     Abstract available
    
    
    
53. WEITZ HH, Merli GJ, Lip GYH
    Annals Consult Guys - The ABCs of Atrial Fibrillation.
    Ann Intern Med. 2024;177:e2400618CG.
    PubMed    
    
    
    
54. FIELD TS
    In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin.
    Ann Intern Med. 2024;177:JC65.
    PubMed     Abstract available
    
    
    
55. CHIA JE, Mukherjee D
    After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
    Ann Intern Med. 2024;177:JC64.
    PubMed     Abstract available
    
    
    May 2024
56. XU W, Lee AL, Lam CLK, Danaei G, et al
    Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.
    Ann Intern Med. 2024 May 28. doi: 10.7326/M24-0004.
    PubMed     Abstract available
    
    
    
57. ALBERTS MJ
    In mild ischemic stroke or high-risk TIA, DAPT started
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0029.
    PubMed     Abstract available
    
    
    
58. LI XRC
    Web Exclusive. Annals Graphic Medicine - Life After a Stroke.
    Ann Intern Med. 2024;177:eG230020.
    PubMed    
    
    
    
59. DUNN A
    In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
    Ann Intern Med. 2024;177:JC57.
    PubMed     Abstract available
    
    
    April 2024
60. DRAKE T, Landsteiner A, Langsetmo L, MacDonald R, et al
    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
    Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-1490.
    PubMed     Abstract available
    
    
    
61. QASEEM A, Obley AJ, Shamliyan T, Hicks LA, et al
    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.
    Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-2788.
    PubMed     Abstract available
    
    
    
62. AJZENBERG H, Binhashr MAN, Hewitt MK, Unger M, et al
    Critical Care: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0565.
    PubMed     Abstract available
    
    
    March 2024
63. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    PubMed     Abstract available
    
    
    February 2024
64. KANJEE Z, Dearborn-Tomazos JL, Kumar S, Reynolds EE, et al
    How Would You Prevent Subsequent Strokes in This Patient? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2024 Feb 13. doi: 10.7326/M23-3136.
    PubMed     Abstract available
    
    
    January 2024
65. FU EL, Carrero JJ, Sang Y, Evans M, et al
    Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C.
    Ann Intern Med. 2024 Jan 30. doi: 10.7326/M23-1138.
    PubMed     Abstract available
    
    
    
66. HILL MD
    After EVT for ischemic stroke, intensive vs. conventional BP management reduced functional independence at 3 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0106.
    PubMed     Abstract available
    
    
    December 2023
67. SUD M, Sivaswamy A, Austin PC, Anderson TJ, et al
    Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2023 Dec 12. doi: 10.7326/M23-1345.
    PubMed     Abstract available
    
    
    
68. AGARWAL R, Tu W, Farjat AE, Farag YMK, et al
    Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
    Ann Intern Med. 2023 Dec 5. doi: 10.7326/M23-1023.
    PubMed     Abstract available
    
    
    
69. WEITZ HH, Merli GJ, Benesch C
    Annals Consult Guys - Surgery After Thromboembolic Stroke.
    Ann Intern Med. 2023;176:eW220025.
    PubMed    
    
    
    November 2023
70. TANG M, Nakamoto CH, Stern AD, Zubizarreta JR, et al
    Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension : An Observational Study.
    Ann Intern Med. 2023 Nov 7. doi: 10.7326/M23-1182.
    PubMed     Abstract available
    
    
    
71. CRUZ-FLORES S
    In healthy older adults, low-dose aspirin did not differ from placebo for ischemic stroke but increased intracranial bleeding.
    Ann Intern Med. 2023 Nov 7. doi: 10.7326/J23-0092.
    PubMed     Abstract available
    
    
    
72. TANNU M, Newby LK
    In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.
    Ann Intern Med. 2023;176:JC123.
    PubMed     Abstract available
    
    
    October 2023
73. EASTIN C
    In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/J23-0072.
    PubMed     Abstract available
    
    
    
74. ALBERTS MJ
    In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/J23-0074.
    PubMed     Abstract available
    
    
    September 2023
75. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events : A Cohort Study.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/M23-0112.
    PubMed     Abstract available
    
    
    
76. KIM DH, Lee SB, Park CM, Levin R, et al
    Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M22-3021.
    PubMed     Abstract available
    
    
    
77. BANNOW BTS
    In adults with cancer and VTE, DOACs were noninferior to LMWH for recurrent, nonfatal VTE at 6 mo.
    Ann Intern Med. 2023;176:JC104.
    PubMed     Abstract available
    
    
    August 2023
78. CARLIN S, Douketis J
    In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level.
    Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0054.
    PubMed     Abstract available
    
    
    
79. BAHREINI M, Lang E
    In ischemic stroke, EVT improved 90-d function more than usual care across admission SBP levels.
    Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0055.
    PubMed     Abstract available
    
    
    
80. KIRSCHNER JM, Hunter BR
    SAEM issued 4 strong recommendations (high-certainty evidence) for determining cause of acute vestibular syndrome in the ED.
    Ann Intern Med. 2023;176:JC86.
    PubMed     Abstract available
    
    
    July 2023
81. MCCORMICK N, Yokose C, Wei J, Lu N, et al
    Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0724.
    PubMed     Abstract available
    
    
    
82. ESKIN B
    In ischemic stroke, adding EVT to usual care at 6 to 24 h improved functional status at 90 d.
    Ann Intern Med. 2023 Jul 4. doi: 10.7326/J23-0050.
    PubMed     Abstract available
    
    
    
83. AL-KHATIB SM
    Atrial Fibrillation.
    Ann Intern Med. 2023;176:ITC97-ITC112.
    PubMed     Abstract available
    
    
    June 2023
84. FERGUSON E, Lang E
    In large acute ischemic stroke, adding endovascular thrombectomy to medical therapy improved function at 90 d.
    Ann Intern Med. 2023 Jun 6. doi: 10.7326/J23-0033.
    PubMed     Abstract available
    
    
    
85. ALBERTS MJ
    After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
    Ann Intern Med. 2023;176:JC71.
    PubMed     Abstract available
    
    
    May 2023
86. RAY WA, Chung CP, Stein CM, Smalley W, et al
    Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
    Ann Intern Med. 2023 May 23. doi: 10.7326/M22-3238.
    PubMed     Abstract available
    
    
    
87. RICHARDSON TL JR, Halvorson AE, Hackstadt AJ, Hung AM, et al
    Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
    Ann Intern Med. 2023 May 9. doi: 10.7326/M22-2751.
    PubMed     Abstract available
    
    
    
88. ZHU J, Kamel H, Gupta A, Mushlin AI, et al
    Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness Analysis.
    Ann Intern Med. 2023 May 2. doi: 10.7326/M22-3186.
    PubMed     Abstract available
    
    
    
89. GRIFFIN M, Lip GYH
    In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.
    Ann Intern Med. 2023;176:JC56.
    PubMed     Abstract available
    
    
    April 2023
90. MARCUCCI M, Painter TW, Conen D, Lomivorotov V, et al
    Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial.
    Ann Intern Med. 2023 Apr 25. doi: 10.7326/M22-3157.
    PubMed     Abstract available
    
    
    
91. ADIE SK, Konerman MC
    Annals for Hospitalists Inpatient Notes - Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction-What Hospitalists Need to Know.
    Ann Intern Med. 2023;176:eM230588.
    PubMed    
    
    
    
92. LADER EW
    After PCI and 6 to 18 mo of DAPT, clopidogrel reduced a composite of clinical events vs. aspirin at 6 y.
    Ann Intern Med. 2023;176:JC38.
    PubMed     Abstract available
    
    
    
93. PERISETTI A, Sharma P
    In older patients receiving aspirin, H pylori eradication reduced hospitalization or death due to peptic ulcer bleeding at 2.5 y.
    Ann Intern Med. 2023;176:JC45.
    PubMed     Abstract available
    
    
    March 2023
94. FORD ND, DeSisto CL, Galang RR, Kuklina EV, et al
    Cardiac Arrest During Delivery Hospitalization : A Cohort Study.
    Ann Intern Med. 2023 Mar 14. doi: 10.7326/M22-2750.
    PubMed     Abstract available
    
    
    
95. CHEW DS, Piccini JP
    Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
    Ann Intern Med. 2023;176:eL220517.
    PubMed    
    
    
    
96. ANDERSON CE, Lieberman RA, Olshansky B
    Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
    Ann Intern Med. 2023;176:eL220516.
    PubMed    
    
    
    
97. DUNN A
    In AF, underdosing of DOACs was not linked to reduced bleeding.
    Ann Intern Med. 2023;176:JC32.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum